Coronary Artery Disease
Conditions
Brief summary
Drug-coated balloon is being used more and more widely for the advantage of intervention without implantation. But the balloon needs to be released long enough to be effective. Prolonged balloon dilation resulting in the cessation of blood flow in the distal vessels, especially large vessels, may result in severe ischemia in the patient. RIPC can enhance patients' tolerance to ischemic events, so we believe that RIPC application before the use of drug balloon for PCI can improve patients' ischemic symptoms, thus increasing the release time of drug balloon and improving the effect.
Detailed description
Some patients receiving PCI cannot tolerate the symptoms of myocardial ischemia caused by the release of the drug balloon for a long time and even lead to the occurrence of adverse events.RIPC was found to improve tolerance to myocardial ischemia in patients. At the same time, it can open collateral circulation and improve the tolerance of myocardial ischemia in patients.Therefore, this study designed a parallel control group. The experimental group was treated with RIPC before PCI, while the control group was not treated before PCI. The operator does not know whether the patient has undergone RIPC or not, and the operator decides the time of drug balloon release according to the symptoms of the patient during the operation.Angiography was performed at 6 months, and QCA was used to determine late lumen loss at 1 year.The 1-year incidence of target lesion failure events was assessed.
Interventions
OTHERRIPC
RIPC is delivered with a standard blood pressure cuff placed on the upper thigh. The cuffs are inflated to 200 mm Hg and keep inflated for 5 minutes,Then deflated to 0 mmHg and keep uninflated for 5 minutes, This cycle is repeated four times
Sponsors
Henan Institute of Cardiovascular Epidemiology
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)
Masking description
Before the operation, the nurse chooses the patient to perform RIPC or not according to a predefined random method, and then the operation is performed by the operator. The operator did not know if the patient had undergone RIPC. Outcome evaluators also did not know the grouping of patients
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Diameter stenosis\>=50% by visual estimation intend to undergo drug-coated balloon implantation * Target vessel diameter\> 2.5mm
Exclusion criteria
* Chronic Total Obstructive lesion * Diagnose patients with acute myocardial infarction \<24 hours * Can't tolerate or not suitable for RIPC * Severe hepatic and renal insufficiency * Expected survival \<1 year * Severe calcification needing rotational atherectomy * Intolerable to dual antiplatelet therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| TLF | 12 months | TLF, a composite of cardiac death, target vessel-related myocardial infarction (MI; not clearly attributed to a nontarget vessel and excluding periprocedural MI), or clinically indicated target lesion revascularization (TLR) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Late lumen loss of target vessel（mm） | 6 months | Late Lumen Loss of target vessel（mm） by Quantitative Coronary Angiography (QCA). |
| DCB expansion time | less than 120 seconds (On the 1 day of PCI) | We hypothesis/speculated that the RIPC group had better ischemia tolerance, so the balloon dilation time was longer than the control group. But the total time for all patients is less than 120 seconds |
Countries
China
Outcome results
None listed